Advance pediatric care using Amazon HealthLake for scalable FHIR-based data analytics
Article courtesy of Amazon Web Service Blog, published December 19, 2022 Blog is guest authored by Meen Chul Kim from Children’s Hospital at Philadelphia The ability to…
Indigenous Inclusion in Sample-based Research
Not only should cultural literacy and respect be prioritized in our daily lives, but both tenets are necessary for quality medical research. The Children’s Brain Tumor Network…
Researchers Uncover New Understanding of Medulloblastoma in CBTN Datasets
Almost all of the DNA of the human genome is located on 23 pairs of chromosomes, each a long coil of a single tightly-wound DNA strand. When a…
CBTN’s Project Accelerate Speeds Up in 2022
Through tireless support and investment from patient families, advocates, and foundations, the Children’s Brain Tumor Network (CBTN) has transformed the landscape of pediatric brain tumor research across the…
CHOP-led Pediatric Hospital Network Receives Critical Government Support for Genetic Research of Pediatric Tumors
Project will allow thousands of tissue samples to be studied and provide an enormous level of insight into childhood cancer PHILADELPHIA, November 2, 2021 – Unlocking the genetic mysteries…
Hack-a-thon Reveals Unexpected Collaboration with Airline Industry
This article was originally published on Wednesday, October 27 as a guest blog entry in Cornerstone, a publication of the Children’s Hospital of Philadelphia’s Research Institute. Editor’s Note: Since its…
Children’s Brain Tumor Network Hosts Annual Investigator Meeting
At each investigator meeting, CBTN presents the latest efforts to connect innovative research happening across its global network, creates opportunities to support young investigators, explores emerging areas of…
ACCELERATE Consortium and Pediatric Brain Tumors Across Appalachia
With its operations center housed at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia (CHOP), Children’s Brain Tumor Network (CBTN) is a…
NF2 Biosolutions
Background Neurofibromatosis 2 (NF2) is a rare genetic disorder that is primarily characterized by noncancerous (benign) tumors of the nerves that transmit balance and sound impulses from the…
Chordoma Foundation Biobank
Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…